Ccr-2 antagonist salt
    1.
    发明申请
    Ccr-2 antagonist salt 失效
    Ccr-2拮抗剂盐

    公开(公告)号:US20070135474A1

    公开(公告)日:2007-06-14

    申请号:US10577584

    申请日:2004-10-25

    IPC分类号: A61K31/4745 C07D471/02

    CPC分类号: C07D471/04

    摘要: The present invention provides an efficient synthesis for the preparation of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine and its succinate salt. The present invention additionally provides an efficient syntheses for the preparation of intermediates (3R)-3-methoxytetrahydro-4H-pyran-4-one; (1 S ,4 S )-4-(2,5-dimethyl-1 H -pyrrol-1-yl)-1-isopropylcyclopent-2-ene-1-carboxylic acid; and 3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine; and for the preparation of the precursor (3S,4S)-N-((1S,4S)-4-isopropyl-4-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopent-2-en-1-yl)-3-methoxytetrahydro-2H-pyran-4-amine. The invention additionally resides in the superior properties of the succinate salt of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine.

    摘要翻译: 本发明提供了制备((1R,3S)-3-异丙基-3 - {[3-(三氟甲基)-7,8-二氢-1,6-二氮杂萘-6(5H) ]羰基}环戊基)[(3S,4S)-3-甲氧基四氢-2H-吡喃-4-基]胺及其琥珀酸盐。 本发明另外提供了制备中间体(3R)-3-甲氧基四氢-4H-吡喃-4-酮的有效合成方法; (1S,4S)-4-(2,5-二甲基-1H - 吡咯-1-基)-1- 异丙基环戊-2-烯-1-羧酸; 和3-(三氟甲基)-5,6,7,8-四氢-1,6-萘啶; 制备前体(3S,4S)-N - ((1S,4S)-4-异丙基-4 - {[3-(三氟甲基)-7,8-二氢-1,6-萘啶-6( 5H) - 基]羰基}环戊-2-烯-1-基)-3-甲氧基四氢-2H-吡喃-4-胺。 本发明还涉及((1R,3S)-3-异丙基-3 - {[3-(三氟甲基)-7,8-二氢-1,6-二氮杂萘-6(5H))的琥珀酸盐的优异性能, - 基]羰基}环戊基)[(3S,4S)-3-甲氧基四氢-2H-吡喃-4-基]胺。

    CCR-2 antagonist salt
    2.
    发明授权
    CCR-2 antagonist salt 失效
    CCR-2拮抗剂盐

    公开(公告)号:US07473696B2

    公开(公告)日:2009-01-06

    申请号:US10577584

    申请日:2004-10-25

    IPC分类号: A61K31/4375 C07D471/04

    CPC分类号: C07D471/04

    摘要: An efficient synthesis for the preparation of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl} cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine and its succinate salt are provided. The succinate salt is crystalline and has superior properties.

    摘要翻译: 制备((1R,3S)-3-异丙基-3 - {[3-(三氟甲基)-7,8-二氢-1,6-二氮杂萘-6(5H) - 基]羰基}环戊基 )[(3S,4S)-3-甲氧基四氢-2H-吡喃-4-基]胺及其琥珀酸盐。 琥珀酸盐是结晶的,具有优异的性能。

    Process for the preparation of CCR-2 antagonists
    3.
    发明授权
    Process for the preparation of CCR-2 antagonists 有权
    制备CCR-2拮抗剂的方法

    公开(公告)号:US07361765B2

    公开(公告)日:2008-04-22

    申请号:US10577587

    申请日:2004-10-25

    IPC分类号: C07D471/02

    摘要: The present invention provides an efficient synthesis for the preparation of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-m ethoxytetrahydro-2H-pyran-4-yl]amine and its succinate salt. The present invention additionally provides an efficient syntheses for the preparation of intermediates (3R)-3-methoxytetrahydro-4H-pyran-4-one; (1S,4S)-4-(2,5-dimethyl-1H-pyrrol-1-yl)-1-isopropylcyclopent-2-ene-1-carboxylic acid; and 3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine; and for the preparation of the precursor (3S,4S)-N-((1S,4S)-4-isopropyl-4-{[3-(tri-fluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopent-2-en-1-yl)-3-methoxytetrahydro-2H-pyran-4-amine. The invention additionally resides in the superior properties of the succinate salt of ((1R,3S)-3-isopropyl-3-1{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine

    摘要翻译: 本发明提供了制备((1R,3S)-3-异丙基-3 - {[3-(三氟甲基)-7,8-二氢-1,6-二氮杂萘-6(5H) ]羰基}环戊基)[(3S,4S)-3-甲氧基四氢-2H-吡喃-4-基]胺及其琥珀酸盐。 本发明另外提供了制备中间体(3R)-3-甲氧基四氢-4H-吡喃-4-酮的有效合成方法; (1S,4S)-4-(2,5-二甲基-1H-吡咯-1-基)-1-异丙基环戊-2-烯-1-羧酸; 和3-(三氟甲基)-5,6,7,8-四氢-1,6-萘啶; 制备前体(3S,4S)-N - ((1S,4S)-4-异丙基-4 - {[3-(三氟甲基)-7,8-二氢-1,6-萘啶-2-基] (5H) - 基]羰基}环戊-2-烯-1-基)-3-甲氧基四氢-2H-吡喃-4-胺。 本发明另外存在((1R,3S)-3-异丙基-3-1 {[3-(三氟甲基)-7,8-二氢-1,6-二氮杂萘-6(5H))的琥珀酸盐的优异性质 ) - 基]羰基}环戊基)[(3S,4S)-3-甲氧基四氢-2H-吡喃-4-基]胺

    Process for the preparation of ccr-2 antagonists
    4.
    发明申请
    Process for the preparation of ccr-2 antagonists 有权
    制备ccr-2拮抗剂的方法

    公开(公告)号:US20070135475A1

    公开(公告)日:2007-06-14

    申请号:US10577587

    申请日:2004-10-25

    IPC分类号: A61K31/4745 C07D471/02

    摘要: The present invention provides an efficient synthesis for the preparation of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-m ethoxytetrahydro-2H-pyran-4-yl]amine and its succinate salt. The present invention additionally provides an efficient syntheses for the preparation of intermediates (3R)-3-methoxytetrahydro-4H-pyran-4-one; (1S,4S)-4-(2,5-dimethyl-1H-pyrrol-1-yl)-1-isopropylcyclopent-2-ene-1-carboxylic acid; and 3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine; and for the preparation of the precursor (3S,4S)-N-((1S,4S)-4-isopropyl-4-{[3-(tri-fluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopent-2-en-1-yl)-3-methoxytetrahydro-2H-pyran-4-amine. The invention additionally resides in the superior properties of the succinate salt of ((1R,3S)-3-isopropyl-3-1{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine.

    摘要翻译: 本发明提供了制备((1R,3S)-3-异丙基-3 - {[3-(三氟甲基)-7,8-二氢-1,6-二氮杂萘-6(5H) ]羰基}环戊基)[(3S,4S)-3-甲氧基四氢-2H-吡喃-4-基]胺及其琥珀酸盐。 本发明另外提供了制备中间体(3R)-3-甲氧基四氢-4H-吡喃-4-酮的有效合成方法; (1S,4S)-4-(2,5-二甲基-1H-吡咯-1-基)-1-异丙基环戊-2-烯-1-羧酸; 和3-(三氟甲基)-5,6,7,8-四氢-1,6-萘啶; 制备前体(3S,4S)-N - ((1S,4S)-4-异丙基-4 - {[3-(三氟甲基)-7,8-二氢-1,6-萘啶-2-基] (5H) - 基]羰基}环戊-2-烯-1-基)-3-甲氧基四氢-2H-吡喃-4-胺。 本发明另外存在((1R,3S)-3-异丙基-3-1 {[3-(三氟甲基)-7,8-二氢-1,6-二氮杂萘-6(5H))的琥珀酸盐的优异性质 ) - 基]羰基}环戊基)[(3S,4S)-3-甲氧基四氢-2H-吡喃-4-基]胺。

    Medical examination table
    7.
    发明申请
    Medical examination table 有权
    体检表

    公开(公告)号:US20070061971A1

    公开(公告)日:2007-03-22

    申请号:US11495185

    申请日:2006-07-28

    IPC分类号: A61G7/00

    摘要: A medical examination table is provided. The medical examination table comprises a base providing a storage area, a patient support movable independent of the base between a lowered position and a raised position, and a lift mechanism coupled to the patient support for moving the patient support between the lowered position and the raised position. The patient support comprises a backrest and a seat. Movement of the patient support independent or separately from the base and without interfering with the storage areas within the base may allow for the efficient use of the examination table as a storage area.

    摘要翻译: 提供体检表。 医疗检查台包括提供存储区域的基座,在下降位置和升高位置之间独立于基座可移动的患者支撑件和联接到患者支架的升降机构,用于使患者支撑件在降低位置和升高的位置之间移动 位置。 患者支架包括靠背和座椅。 与基座独立或分离而不干扰基座内的存储区域的患者支架的运动可允许有效地使用检查台作为存储区域。

    Systems and methods for asynchronous transfer mode and internet protocol
    8.
    发明授权
    Systems and methods for asynchronous transfer mode and internet protocol 有权
    用于异步传输模式和互联网协议的系统和方法

    公开(公告)号:US07058027B1

    公开(公告)日:2006-06-06

    申请号:US09787300

    申请日:1999-09-16

    IPC分类号: H04B7/00 H04J3/16

    摘要: A protocol-independent error-control system includes several components (840a, 830a, 820a, 150b, 820b, 830b, 840b) that assist in providing more reliable data transmission between endpoints (110, 120): 1) an ATM adaptation layer that supports quality-critical and time-critical data; 2) a rate converter that uses a priority scheme to adjust the data rate for different types of data; and 3) an error-control subsystem that implements a data link protocol optimized for error-prone links, and capable of recognizing traffic from many kinds of network sources. The error-control subsystem may be used alone or in combination with the ATM adaptation layer (170, 172, 180, 182) and/or the rate converter (830).

    摘要翻译: 协议无关的误差控制系统包括有助于在端点(110,120)之间提供更可靠的数据传输的若干组件(840a,830a,820a,150b,820b,830b,840b):1 )ATM适配层,支持质量关键和时间关键的数据; 2)使用优先级方案来调整不同类型数据的数据速率的速率转换器; 以及3)错误控制子系统,其实现针对容易出错的链路优化的数据链路协议,并且能够识别来自多种网络源的流量。 误差控制子系统可以单独使用或与ATM适配层(170,172,180,182)和/或速率转换器(830)组合使用。

    MULTIPLEX PCR MIXTURES AND KITS CONTAINING THE SAME
    10.
    发明申请
    MULTIPLEX PCR MIXTURES AND KITS CONTAINING THE SAME 审中-公开
    MULTIPLEX PCR混合物和包含它的试剂盒

    公开(公告)号:US20070231803A1

    公开(公告)日:2007-10-04

    申请号:US11394588

    申请日:2006-03-31

    申请人: Mark Jensen

    发明人: Mark Jensen

    IPC分类号: C12Q1/68 C12P19/34

    摘要: A multiplex PCR reaction mixture is provided. In one embodiment, the reaction mixture contains a plurality of primer pairs that bind to genomic DNA for producing predetermined amplification products of a range of different sizes, where each primer pair is at a concentration that is selected for production of a pre-determined amount of amplification product if the genomic DNA is intact. Also provided are methods of using the reaction mixture.

    摘要翻译: 提供多重PCR反应混合物。 在一个实施方案中,反应混合物含有多个与基因组DNA结合的引物对,用于产生不同大小范围的预定扩增产物,其中每个引物对的浓度选择用于产生预定量的 扩增产物,如果基因组DNA是完整的。 还提供使用反应混合物的方法。